Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
SteadyMed Ltd. (STDY) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2018 8-K Quarterly results
Docs: "SteadyMed Provides Corporate Update and Reports Second Quarter 2018 Financial Results"
03/30/2018 8-K Quarterly results
Docs: "SteadyMed Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results Company on Track for Trevyent™ NDA Resubmission"
11/13/2017 8-K Quarterly results
Docs: "SteadyMed Reports Third Quarter 2017 Financial Results and Provides Corporate Update"
08/11/2017 8-K Quarterly results
Docs: "SteadyMed Reports Second Quarter 2017 Financial Results and Provides Corporate Update"
05/12/2017 8-K Form 8-K - Current report
03/29/2017 8-K Form 8-K - Current report
11/14/2016 8-K Form 8-K - Current report
08/15/2016 8-K Quarterly results
Docs: "STEADYMED PROVIDES CORPORATE UPDATE AND REPORTS SECOND QUARTER 2016 FINANCIAL RESULTS SAN RAMON, Calif., August 15, 2016 — SteadyMed Ltd. , a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with unmet parenteral delivery needs, today provided a corporate update and announced its financial results for the second quarter ended June 30, 2016. First Half 2016 Corporate Update:"
05/11/2016 8-K Quarterly results
Docs: "SteadyMed Provides Corporate Update and Reports First Quarter 2016 Financial Results"
03/29/2016 8-K Form 8-K - Current report
11/12/2015 8-K Quarterly results
Docs: "STEADYMED REPORTS RECENT DEVELOPMENTS AND THIRD QUARTER 2015 FINANCIAL RESULTS"
08/13/2015 8-K Quarterly results
Docs: "STEADYMED PROVIDES INSIGHTS ON RECENT CORPORATE DEVELOPMENTS AND REPORTS SECOND QUARTER 2015 FINANCIAL RESULTS"
05/14/2015 8-K Quarterly results
Docs: "STEADYMED REPORTS RECENT DEVELOPMENTS, FINANCIAL HIGHLIGHTS AND FIRST QUARTER 2015 FINANCIAL RESULTS"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy